BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 20525894)

  • 1. TLR4-mediated sensing of Campylobacter jejuni by dendritic cells is determined by sialylation.
    Kuijf ML; Samsom JN; van Rijs W; Bax M; Huizinga R; Heikema AP; van Doorn PA; van Belkum A; van Kooyk Y; Burgers PC; Luider TM; Endtz HP; Nieuwenhuis EE; Jacobs BC
    J Immunol; 2010 Jul; 185(1):748-55. PubMed ID: 20525894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sialylation of Campylobacter jejuni endotoxin promotes dendritic cell-mediated B cell responses through CD14-dependent production of IFN-β and TNF-α.
    Huizinga R; van Rijs W; Bajramovic JJ; Kuijf ML; Laman JD; Samsom JN; Jacobs BC
    J Immunol; 2013 Dec; 191(11):5636-45. PubMed ID: 24166974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural characterization of Campylobacter jejuni lipooligosaccharide outer cores associated with Guillain-Barre and Miller Fisher syndromes.
    Godschalk PC; Kuijf ML; Li J; St Michael F; Ang CW; Jacobs BC; Karwaski MF; Brochu D; Moterassed A; Endtz HP; van Belkum A; Gilbert M
    Infect Immun; 2007 Mar; 75(3):1245-54. PubMed ID: 17261613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular mimicry in Campylobacter jejuni: role of the lipo-oligosaccharide core oligosaccharide in inducing anti-ganglioside antibodies.
    Perera VN; Nachamkin I; Ung H; Patterson JH; McConville MJ; Coloe PJ; Fry BN
    FEMS Immunol Med Microbiol; 2007 Jun; 50(1):27-36. PubMed ID: 17374131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibodies induced by ganglioside-mimicking Campylobacter jejuni lipooligosaccharides recognise epitopes at the nodes of Ranvier.
    Moran AP; Annuk H; Prendergast MM
    J Neuroimmunol; 2005 Aug; 165(1-2):179-85. PubMed ID: 15993494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recognition characteristics of monoclonal antibodies that are cross-reactive with gangliosides and lipooligosaccharide from Campylobacter jejuni strains associated with Guillain-Barré and Fisher syndromes.
    Houliston RS; Yuki N; Hirama T; Khieu NH; Brisson JR; Gilbert M; Jarrell HC
    Biochemistry; 2007 Jan; 46(1):36-44. PubMed ID: 17198373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Campylobacter jejuni lipooligosaccharides modulate dendritic cell-mediated T cell polarization in a sialic acid linkage-dependent manner.
    Bax M; Kuijf ML; Heikema AP; van Rijs W; Bruijns SC; García-Vallejo JJ; Crocker PR; Jacobs BC; van Vliet SJ; van Kooyk Y
    Infect Immun; 2011 Jul; 79(7):2681-9. PubMed ID: 21502591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carbohydrate mimicry of Campylobacter jejuni lipooligosaccharide is critical for the induction of anti-GM1 antibody and neuropathy.
    Shu XM; Cai FC; Zhang XP
    Muscle Nerve; 2006 Feb; 33(2):225-31. PubMed ID: 16270308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Campylobacter gene polymorphism as a determinant of clinical features of Guillain-Barré syndrome.
    Koga M; Takahashi M; Masuda M; Hirata K; Yuki N
    Neurology; 2005 Nov; 65(9):1376-81. PubMed ID: 16162859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Campylobacter coli enteritis and Guillain-Barré syndrome: no evidence of molecular mimicry and serological relationship.
    Funakoshi K; Koga M; Takahashi M; Hirata K; Yuki N
    J Neurol Sci; 2006 Jul; 246(1-2):163-8. PubMed ID: 16600306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brucella melitensis infection associated with Guillain-Barré syndrome through molecular mimicry of host structures.
    Watanabe K; Kim S; Nishiguchi M; Suzuki H; Watarai M
    FEMS Immunol Med Microbiol; 2005 Aug; 45(2):121-7. PubMed ID: 16051063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipopolysaccharides in the development of the Guillain-Barré syndrome and Miller Fisher syndrome forms of acute inflammatory peripheral neuropathies.
    Prendergast MM; Moran AP
    J Endotoxin Res; 2000; 6(5):341-59. PubMed ID: 11521055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sialylation of Campylobacter jejuni lipo-oligosaccharides: impact on phagocytosis and cytokine production in mice.
    Huizinga R; Easton AS; Donachie AM; Guthrie J; van Rijs W; Heikema A; Boon L; Samsom JN; Jacobs BC; Willison HJ; Goodyear CS
    PLoS One; 2012; 7(3):e34416. PubMed ID: 22470569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Siglec-7 specifically recognizes Campylobacter jejuni strains associated with oculomotor weakness in Guillain-Barré syndrome and Miller Fisher syndrome.
    Heikema AP; Jacobs BC; Horst-Kreft D; Huizinga R; Kuijf ML; Endtz HP; Samsom JN; van Wamel WJ
    Clin Microbiol Infect; 2013 Feb; 19(2):E106-12. PubMed ID: 23173866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced, sialoadhesin-dependent uptake of Guillain-Barre syndrome-associated Campylobacter jejuni strains by human macrophages.
    Heikema AP; Koning RI; Duarte dos Santos Rico S; Rempel H; Jacobs BC; Endtz HP; van Wamel WJ; Samsom JN
    Infect Immun; 2013 Jun; 81(6):2095-103. PubMed ID: 23529622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Guillain-Barré syndrome-related Campylobacter jejuni in Bangladesh: ganglioside mimicry and cross-reactive antibodies.
    Islam Z; Gilbert M; Mohammad QD; Klaij K; Li J; van Rijs W; Tio-Gillen AP; Talukder KA; Willison HJ; van Belkum A; Endtz HP; Jacobs BC
    PLoS One; 2012; 7(8):e43976. PubMed ID: 22952833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Innate Immunity to Campylobacter jejuni in Guillain-Barré Syndrome.
    Huizinga R; van den Berg B; van Rijs W; Tio-Gillen AP; Fokkink WJ; Bakker-Jonges LE; Geleijns K; Samsom JN; van Doorn PA; Laman JD; Jacobs BC
    Ann Neurol; 2015 Sep; 78(3):343-54. PubMed ID: 26017721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive analysis of bacterial risk factors for the development of Guillain-Barre syndrome after Campylobacter jejuni enteritis.
    Koga M; Gilbert M; Takahashi M; Li J; Koike S; Hirata K; Yuki N
    J Infect Dis; 2006 Feb; 193(4):547-55. PubMed ID: 16425134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The sialic acid residue is a crucial component of C. jejuni lipooligosaccharide ganglioside mimicry in the induction Guillain-Barré syndrome.
    Xiang SL; Zhong M; Cai FC; Deng B; Zhang XP
    J Neuroimmunol; 2006 May; 174(1-2):126-32. PubMed ID: 16567003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Campylobacter sialyltransferase gene polymorphism directs clinical features of Guillain-Barré syndrome.
    Yuki N
    J Neurochem; 2007 Nov; 103 Suppl 1():150-8. PubMed ID: 17986150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.